The earlier, the better

Interested parties can read all the details of the 6-year study in the journal "Ophthalmic and Physiological Optics". The peer review "Six-Year Cumulative Treatment Efficacy of a Dual Focus Myopia Control Contact Lens" published there by the UK College of Optometrists is also freely accessible at https://doi.org/10.1111/opo.13240.

CooperVision has also published a video interview with two co-authors of the study on the Myopia Profile platform. In it, Paul Giffort and Kate Gifford from Myopia Profile discuss the effectiveness of MiSight with CooperVision's research and development managers, Arthur Bradley and Paul Chamberlain 1 day based on the study results. "Our study answers pressing questions from contact lens specialists about the long-term effectiveness of myopia management with MiSight 1 day," explains Chamberlain. "The study results clearly show that the disposable contact lens slows the progression of myopia. The detailed multi-center study design and the long study period of six years underpin the significance of the study. The publication shows contact lens specialists worldwide an evidence-based approach to halt the progression of increasing myopia in children".

The work shows that earlier myopia progression, emmetropic eye length growth and analysis methods for slowing progression can also be used to assess the effectiveness of myopia management. This is an important finding, as the age of the affected children means that a control group must be omitted for ethical reasons.

MiSight 1 day one-day contact lenses slowed eye growth to less than half of the growth observed in short-sighted children without MiSight 1 day. The eye growth of the children with the corrective lens thus corresponded to the normal growth rates of children without visual impairment. The research results also showed that the probability of eye growth of more than 0.3 millimeters within one to three years decreases by 95 percent in myopic children aged 8 to 12 years.

The study shows that short-sighted children should be fitted with MiSight 1 day as early as possible. The earlier they start wearing the corrective lens, the better the progression of myopia can be halted. In the long term, this can lead to

• no need for costly vision correction later on.
• the visual defect does not deteriorate further between check-ups.
• the development and education of children is not impaired by myopia.
• the children do not suffer from serious eye diseases later on.

MiSight 1 day from CooperVision, which is now available in more than 30 countries, is the first and only soft contact lens approved by the US Food and Drug Administration (FDA) for the correction of myopia and slowing the progression of myopia in children aged eight to twelve years. It is also the first soft contact lens approved by the Chinese NMPA with an indication to slow the progression of myopia in children aged eight to twelve at the start of treatment with a refraction of -0.75 diopters to -4.00 diopters and an astigmatism of 0.75 diopters. The MiSight 1 day is also CE-marked.

CooperVision also offers a range of orthokeratology contact lenses and ophthalmic lenses with Diffusion Optics Technology™ for myopia management.